Literature DB >> 22411572

Duodenal-jejunal bypass surgery enhances glucose tolerance and beta-cell function in Western diet obese rats.

Allan Cezar Faria Araujo1, Maria Lúcia Bonfleur, Sandra Lucinei Balbo, Rosane Aparecida Ribeiro, Alexandre Coutinho Teixeira de Freitas.   

Abstract

BACKGROUND: The aim of this study was to investigate the effect of the duodenal-jejunal bypass (DJB) on glucose homeostasis and islet insulin secretion in Western diet (WD) obese rats.
METHODS: Male Wistar rats received a standard rodent chow diet (CTL group) or WD ad libitum. After 32 weeks of diet, WD rats were submitted to duodenal-jejunal bypass (WD DJB) or sham (WD S-DJB) operation. Intraperitoneal (ip) glucose tolerance test was performed 1 week after surgery. Body weight, fat pad depots, glycemia, insulinemia, HOMA-IR, and glucose-induced insulin secretion were evaluated 1 month after surgery.
RESULTS: Body weight and fat pads of the WD group were higher than those of the CTL group. Sham and DJB surgeries did not alter these parameters. WD and WD S-DJB rats were glucose intolerant, insulin resistant, and hyperinsulinemic. WD DJB rats showed similar glucose tolerance, insulin sensitivity, and plasma insulin levels to those of CTL rats. WD rats presented higher fat and glycogen contents in the liver. DJB surgery normalized fat and glycogen stores in the liver of the WD DJB group. Insulin release at 11.1-mM glucose, in isolated islets from WD and WD S-DJB rats, was higher than from islets of CTL rats. In contrast, DJB surgery improves the beta-cell secretory capacity with increased glucose-induced secretion at 5.6-, 11.1-, and 22.2-mM glucose in WD DJB islets, compared with CTL islets.
CONCLUSIONS: DJB surgery improves glucose homeostasis and enhances beta-cell glucose responsiveness in rats submitted to the WD diet without any modification in adiposity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22411572     DOI: 10.1007/s11695-012-0630-3

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  40 in total

1.  Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function.

Authors:  A Mari; M Manco; C Guidone; G Nanni; M Castagneto; G Mingrone; E Ferrannini
Journal:  Diabetologia       Date:  2006-07-04       Impact factor: 10.122

Review 2.  Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities.

Authors:  Miriam Cnop; Nils Welsh; Jean-Christophe Jonas; Anne Jörns; Sigurd Lenzen; Decio L Eizirik
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

3.  The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes.

Authors:  Francesco Rubino; Antonello Forgione; David E Cummings; Michel Vix; Donatella Gnuli; Geltrude Mingrone; Marco Castagneto; Jacques Marescaux
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

Review 4.  Obesity, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations for metabolic diversity.

Authors:  S E Kahn; R L Prigeon; R S Schwartz; W Y Fujimoto; R H Knopp; J D Brunzell; D Porte
Journal:  J Nutr       Date:  2001-02       Impact factor: 4.798

5.  Estimation of body fat in normal and obese mice.

Authors:  P Rogers; G P Webb
Journal:  Br J Nutr       Date:  1980-01       Impact factor: 3.718

6.  How obesity causes diabetes: not a tall tale.

Authors:  Mitchell A Lazar
Journal:  Science       Date:  2005-01-21       Impact factor: 47.728

7.  Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease.

Authors:  Francesco Rubino; Jacques Marescaux
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

8.  Pregnancy restores insulin secretion from pancreatic islets in cafeteria diet-induced obese rats.

Authors:  E C Vanzela; R A Ribeiro; C A Machado de Oliveira; F B Rodrigues; M L Bonfleur; E M Carneiro; K L A Souza; A C Boschero
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-11-11       Impact factor: 3.619

9.  Ileal interposition improves glucose tolerance in low dose streptozotocin-treated diabetic and euglycemic rats.

Authors:  April D Strader; Trine Ryberg Clausen; Sean Z Goodin; Donna Wendt
Journal:  Obes Surg       Date:  2008-11-07       Impact factor: 4.129

10.  First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery.

Authors:  Serenella Salinari; Alessandro Bertuzzi; Simone Asnaghi; Caterina Guidone; Melania Manco; Geltrude Mingrone
Journal:  Diabetes Care       Date:  2008-11-25       Impact factor: 19.112

View more
  7 in total

1.  Vagotomy diminishes obesity in cafeteria rats by decreasing cholinergic potentiation of insulin release.

Authors:  Sandra Lucinei Balbo; Rosane Aparecida Ribeiro; Mariana Carla Mendes; Camila Lubaczeuski; Ana Claudia Paiva Alegre Maller; Everardo Magalhães Carneiro; Maria Lúcia Bonfleur
Journal:  J Physiol Biochem       Date:  2016-06-28       Impact factor: 4.158

2.  Duodeno-jejunal bypass restores β-cell hypersecretion and islet hypertrophy in western diet obese rats.

Authors:  Mariana Carla Mendes; Maria Lúcia Bonfleur; Rosane Aparecida Ribeiro; Camila Lubaczeuski; Ana Flavia Justino Fêo; Rodrigo Vargas; Everardo Magalhães Carneiro; Antonio Carlos Boschero; Allan Cezar Faria Araujo; Sandra Lucinei Balbo
Journal:  Endocrine       Date:  2018-03-19       Impact factor: 3.633

3.  Duodenal-jejunal bypass surgery suppresses hepatic de novo lipogenesis and alleviates liver fat accumulation in a diabetic rat model.

Authors:  Haifeng Han; Chunxiao Hu; Lei Wang; Guangyong Zhang; Shaozhuang Liu; Feng Li; Dong Sun; Sanyuan Hu
Journal:  Obes Surg       Date:  2014-12       Impact factor: 4.129

4.  Duodenal-jejunal bypass restores insulin action and βeta-cell function in hypothalamic-obese rats.

Authors:  Maria Lúcia Bonfleur; Rosane Aparecida Ribeiro; Audrei Pavanello; Raul Soster; Camila Lubaczeuski; Allan Cezar Faria Araujo; Antonio Carlos Boschero; Sandra Lucinei Balbo
Journal:  Obes Surg       Date:  2015-04       Impact factor: 4.129

5.  Duodenal-jejunal bypass improves glucose metabolism and adipokine expression independently of weight loss in a diabetic rat model.

Authors:  Chunxiao Hu; Guangyong Zhang; Dong Sun; Haifeng Han; Sanyuan Hu
Journal:  Obes Surg       Date:  2013-09       Impact factor: 4.129

6.  Duodenal-Jejunal Bypass Surgery Reverses Diabetic Phenotype and Reduces Obesity in db/db Mice.

Authors:  Yongjun Liang; Yueqian Wang; Zhengdong Qiao; Ting Cao; Ying Feng; Lin Zhang; Peng Zhang
Journal:  Curr Chem Genom Transl Med       Date:  2017-10-31

7.  Duodenal-jejunal bypass normalizes pancreatic islet proliferation rate and function but not hepatic steatosis in hypothalamic obese rats.

Authors:  K R Cantelli; G M Soares; R A Ribeiro; S L Balbo; C Lubaczeuski; A C Boschero; A C F Araújo; M L Bonfleur
Journal:  Braz J Med Biol Res       Date:  2017-03-30       Impact factor: 2.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.